In response to the opioid epidemic, many states, including Texas, created prescription drug monitoring programs to monitor high-risk patients and provider behaviors. The Texas Prescription Drug Monitoring Program (“PMP”) is...more
2/18/2020
/ Compliance Monitoring ,
Controlled Substances ,
Databases ,
Dentists ,
Document Retention Policies ,
Drug & Alcohol Abuse ,
Drug Distribution ,
Health Care Providers ,
Healthcare Reform ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Pharmacies ,
Physician Assistants ,
Physicians ,
Prescribing Authority ,
Prescription Drugs ,
Public Health ,
Public Safety ,
Regulatory Requirements ,
Risk Management ,
Substance Abuse
The U.S. Department of Health and Human Services, Office of Inspector General (“OIG”) recently released Advisory Opinion 18-10, which approved a proposed arrangement involving a manufacturer of medical devices and wound care...more